Skip to content

On this page

Ilumya

tildrakizumab-asmn

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Ilumya

Proper name

tildrakizumab-asmn

Licence type

351(a)

BLA number

761067

Applicant

Sun Pharmaceutical Industries Limited

Center

CDER

Presentations

1

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
100MG/ML	Injection	Subcutaneous	Pre-Filled Syringe	Rx	March 20, 2018

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity